VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+5.48%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$94.3M
AUM Growth
+$94.3M
(-12%)
Cap. Flow
-$7.65M
Cap. Flow
% of AUM
-8.1%
Top 10 Holdings %
Top 10 Hldgs %
88.82%
Holding
29
New
5
Increased
6
Reduced
3
Closed
6
Top Buys
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$3.63M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$2.38M |
| 3 |
QIPT
Quipt Home Medical
QIPT
|
$1.4M |
| 4 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$1.02M |
| 5 |
Healthcare Services Group
HCSG
|
$871K |
Top Sells
| 1 |
ATRS
Antares Pharma, Inc.
ATRS
|
$5.52M |
| 2 |
Lantheus
LNTH
|
$3.39M |
| 3 |
RAPT Therapeutics
RAPT
|
$2.42M |
| 4 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
$1.91M |
| 5 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$1.89M |
Sector Composition
| 1 | Healthcare | 78.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|
|
CMRX
27
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-400,000
| Closed | -$1.83M |
|
|
SLGC
28
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| – | – |
-235,300
| Closed | -$1.89M |
|
|
ATRS
29
DELISTED
Antares Pharma, Inc.
ATRS
| – | – |
-1,346,971
| Closed | -$5.52M |
|